UPFRONT SURGERY AS FIRST-LINE TREATMENT IN PATHOLOGICAL N2 NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Bertolaccini, L. [1 ]
Prisciandaro, E. [1 ]
Sedda, G. [1 ]
Girelli, L. [1 ]
Ieo, L. Spaggiari [1 ]
机构：
[1] European Inst Oncol, Thorac Surg, Milan, Italy
来源：
CHEST | 2022年 / 161卷 / 06期
关键词：
lung cancer;
D O I：
10.1016/j.chest.2021.12.345
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：315A / 315A
页数：1
相关论文
共 50 条
  • [21] Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
    Martinez, Pablo
    Peters, Solange
    Stammers, Timothy
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2691 - 2698
  • [22] What Is the Standard First-Line Treatment for Advanced Non-Small Cell Lung Cancer?
    Ricciuti, Biagio
    Awad, Mark M.
    CANCER JOURNAL, 2020, 26 (06): : 485 - 495
  • [23] Surgery in microscopically pathological N2 non-small cell lung cancer: the size of lymph node matters
    Lee, Ming-Ching
    Hsu, Chung-Ping
    JOURNAL OF THORACIC DISEASE, 2017, 9 (02) : 230 - 232
  • [24] First-Line Systemic Therapy for Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 59 - +
  • [25] Non-small cell Lung Cancer Personalization of First-Line Therapy
    Schmale, Ine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (05)
  • [26] Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer
    Yun, Jae Kwang
    Bok, Jin San
    Lee, Geun Dong
    Kim, Hyeong Ryul
    Kim, Yong-Hee
    Kim, Dong Kwan
    Park, Seung-Il
    Choi, Sehoon
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (01) : 59 - 69
  • [27] TREATMENT OF N2 NON-SMALL CELL LUNG-CANCER (NSCLC)
    KLASTERSKY, J
    FELD, R
    KLEISBAUER, JP
    ROCMANS, P
    CHEST, 1989, 96 (01) : S83 - S85
  • [28] Results of N1 and N2 surgery in non-small cell lung cancer
    Pfannschmidt, J.
    Kollmeier, J.
    CHIRURG, 2019, 90 (12): : 974 - 981
  • [29] Prognostic factors in resectable pathological N2 disease of non-small cell lung cancer
    Hsieh, Chen-Ping
    Fu, Jui-Ying
    Liu, Yun-Hen
    Yang, Cheng-Ta
    Hsieh, Ming-Ju
    Tsai, Ying-Huang
    Wu, Yi-Cheng
    Wu, Ching-Yang
    BIOMEDICAL JOURNAL, 2015, 38 (04) : 329 - 335
  • [30] Prognostic Factors in Patients with Resected Pathological N2 Non-Small Cell Lung Cancer
    Goto, T.
    Nakamura, M.
    Shimizu, Y.
    Sato, S.
    Koike, T.
    Tsuchida, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S879 - S879
12345